# Akili Interactive

> Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. Last analyzed August 9, 2026.

> Akili Interactive is a company that develops and delivers a new class of digital medicines in the form of captivating video games to treat cognitive impairments. Their products, EndeavorRx and EndeavorOTC, are clinically proven game-based treatments for ADHD in children and adults, respectively, with EndeavorRx being the first FDA-authorized prescription video game.

- Business Profile: https://optimly.ai/brand/akili-interactive
- Publisher: Optimly (https://optimly.ai)
- Dataset: Optimly AI Brand Index (https://optimly.ai/brand)
- Official website: https://akiliinteractive.com/
- Logo: https://logo.clearbit.com/akiliinteractive.com
- Slug: akili-interactive
- Brand Authority Index tier: Emerging
- Archetype: Challenger
- Category: Digital Therapeutics
- Last Analyzed: August 9, 2026

## Buyer Intent Signals
Problems: Traditional Behavioral Therapy: Patients engage in face-to-face or telehealth sessions with therapists to learn coping strategies, organizational skills, and attention-building techniques for ADHD. | ADHD Specialty Clinics: Clinics that provide comprehensive diagnostic assessments, medication management, and integrated behavioral interventions for individuals with ADHD. | Continue without specialized intervention: Individuals might attempt to manage ADHD symptoms through personal strategies or compensatory behaviors without formal treatment, potentially leading to ongo
Solutions: Akili Interactive ADHD | game based treatment for ADHD | FDA approved video game ADHD | digital therapeutics cognitive impairment | Akili Interactive stock | Non-FDA Approved Brain Training Apps: Various mobile applications offering brain games and cognitive exercises without clinical validation or regulatory approval for therapeutic claims, often marketed